EA003989B1 - Композиция (варианты) и способ лечения или профилактики инфекции гриппа у млекопитающего - Google Patents

Композиция (варианты) и способ лечения или профилактики инфекции гриппа у млекопитающего Download PDF

Info

Publication number
EA003989B1
EA003989B1 EA200000332A EA200000332A EA003989B1 EA 003989 B1 EA003989 B1 EA 003989B1 EA 200000332 A EA200000332 A EA 200000332A EA 200000332 A EA200000332 A EA 200000332A EA 003989 B1 EA003989 B1 EA 003989B1
Authority
EA
Eurasian Patent Office
Prior art keywords
independently
carbon atoms
group
groups
substituted
Prior art date
Application number
EA200000332A
Other languages
English (en)
Russian (ru)
Other versions
EA200000332A1 (ru
Inventor
Норберт У. Бишофбергер
Теренс К. Дал
Чанг Ю. Ким
Хонгтао Лиу
Уиллард Лью
Роджер Г. Милз
Метью Э. Уильямс
Майкл Дж. М. Хичкок
Original Assignee
Джилид Сайэнс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джилид Сайэнс, Инк. filed Critical Джилид Сайэнс, Инк.
Publication of EA200000332A1 publication Critical patent/EA200000332A1/ru
Publication of EA003989B1 publication Critical patent/EA003989B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/52—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
EA200000332A 1997-09-17 1998-09-15 Композиция (варианты) и способ лечения или профилактики инфекции гриппа у млекопитающего EA003989B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5930897P 1997-09-17 1997-09-17
US93864497A 1997-09-26 1997-09-26
US6019597P 1997-09-26 1997-09-26
PCT/US1998/019355 WO1999014185A1 (en) 1997-09-17 1998-09-15 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments

Publications (2)

Publication Number Publication Date
EA200000332A1 EA200000332A1 (ru) 2000-10-30
EA003989B1 true EA003989B1 (ru) 2003-12-25

Family

ID=27369627

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000332A EA003989B1 (ru) 1997-09-17 1998-09-15 Композиция (варианты) и способ лечения или профилактики инфекции гриппа у млекопитающего

Country Status (15)

Country Link
EP (1) EP1015417A1 (enExample)
JP (1) JP2001516739A (enExample)
KR (1) KR20010024123A (enExample)
CN (1) CN1272105A (enExample)
AR (1) AR013960A1 (enExample)
AU (1) AU747702B2 (enExample)
BR (1) BR9812649A (enExample)
CA (1) CA2303323A1 (enExample)
EA (1) EA003989B1 (enExample)
ID (1) ID25516A (enExample)
IL (1) IL134691A0 (enExample)
IN (1) IN190983B (enExample)
NZ (1) NZ502988A (enExample)
TR (1) TR200000723T2 (enExample)
WO (1) WO1999014185A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2633085C2 (ru) * 2014-05-20 2017-10-11 Российская Федерация, от имени которой выступает Федеральное государственное казенное учреждение "Войсковая часть 68240" Противовирусное лекарственное средство в виде капсул и способ его получения

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9813480A (pt) * 1997-12-17 2000-10-10 Biocryst Pharm Inc Compostos inibidores de neuraminidase de ciclopentano substituìdo, composição e métodos de inibição da neuraminidase do vìrus da influenza- e de tratamento de infecção por vìrus da influenza-
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
ES2198244T3 (es) * 1999-06-11 2004-02-01 F. Hoffmann-La Roche Ag Procedimiento para la preparacion de inhibidor ro-64-0796 de la neuraminidasa.
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
BR0010525A (pt) * 1999-10-19 2002-11-26 Abbott Lab cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase
JP2001131144A (ja) * 1999-11-02 2001-05-15 Sagami Chem Res Center ７−アザビシクロ［４．１．０］ヘプト−３−エン−３−カルボン酸エステル類の製造方法
US6403824B2 (en) 2000-02-22 2002-06-11 Hoffmann-La Roche Inc. Process for the preparation for 4,5-diamino shikimic acid derivatives
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
CN101351438A (zh) * 2005-12-28 2009-01-21 弗·哈夫曼-拉罗切有限公司 在合成达菲中的环氧化物中间体
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
WO2011059994A2 (en) * 2009-11-11 2011-05-19 3M Innovative Properties Company Polymeric compositions and method of making and articles thereof
DE102011117128A1 (de) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
CN102659615B (zh) * 2012-05-09 2014-05-07 中国药科大学 奥司他韦衍生物、其制备方法及其医药用途
RU2520836C1 (ru) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-амино-5-(2,2-дифторацетиламино)-3-(1-этилпропокси)-циклогекс-1-енкарбоновая кислота и ее эфиры, способ их получения и применения
CN105439884A (zh) * 2015-10-27 2016-03-30 沈阳药科大学 一种奥司他韦的制备方法
CN108047076B (zh) * 2017-12-26 2020-05-08 杭州新博思生物医药有限公司 一种奥司他韦对映异构体的制备方法
CN110194728B (zh) * 2019-06-19 2021-04-30 湖南华腾制药有限公司 磷酸奥司他韦中间体的连续化合成方法
CN114057599A (zh) * 2020-07-29 2022-02-18 广州市恒诺康医药科技有限公司 神经氨酸酶抑制剂类化合物、其药物组合物及其用途
CN116375595A (zh) * 2023-03-31 2023-07-04 重庆医药高等专科学校 一种磷酸奥司他韦的制备方法及精制方法
CN117105801A (zh) * 2023-07-24 2023-11-24 四川青木制药有限公司 一种奥司他韦及其磷酸盐的制备方法及其中间体
CN116666669B (zh) * 2023-07-25 2023-10-03 四川大学 VN负载的Ir团簇及其制备方法与其在催化剂中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
SI9620042A (sl) * 1995-02-27 1998-12-31 Gilead Sciences, Inc. Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
EP0920410B1 (en) * 1996-08-23 2002-03-27 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2633085C2 (ru) * 2014-05-20 2017-10-11 Российская Федерация, от имени которой выступает Федеральное государственное казенное учреждение "Войсковая часть 68240" Противовирусное лекарственное средство в виде капсул и способ его получения

Also Published As

Publication number Publication date
KR20010024123A (ko) 2001-03-26
AR013960A1 (es) 2001-01-31
IL134691A0 (en) 2001-04-30
EP1015417A1 (en) 2000-07-05
IN190983B (enExample) 2003-09-06
WO1999014185A1 (en) 1999-03-25
JP2001516739A (ja) 2001-10-02
AU747702B2 (en) 2002-05-16
TR200000723T2 (tr) 2001-06-21
ID25516A (id) 2000-10-05
AU9569498A (en) 1999-04-05
CN1272105A (zh) 2000-11-01
BR9812649A (pt) 2000-08-22
EA200000332A1 (ru) 2000-10-30
CA2303323A1 (en) 1999-03-25
NZ502988A (en) 2002-08-28

Similar Documents

Publication Publication Date Title
EA003989B1 (ru) Композиция (варианты) и способ лечения или профилактики инфекции гриппа у млекопитающего
CZ297945B6 (cs) Nové selektivní inhibitory virových nebo bakteriálních neuraminidáz, farmaceutické prostredky tyto inhibitory obsahující a pouzití inhibitoru
US12152017B2 (en) Ketoamide compound and preparation method, pharmaceutical composition, and use thereof
JP5372751B2 (ja) Ａｚａ−ペプチドプロテアーゼ阻害剤
CA3139977A1 (en) Peptidomimetics for the treatment of coronavirus and picornavirus infections
EP3341007B1 (en) Malt1 inhibitors and uses thereof
CN105339351A (zh) 精氨酸甲基转移酶抑制剂及其用途
EA019419B1 (ru) Фосфонатные аналоги соединений ингибиторов вич, фармацевтическая композиция и набор, их включающие, и способ лечения нарушений, ассоциированных с вич
EP3277675B1 (en) Heterocyclic modulators of lipid synthesis
US20230133600A1 (en) Pharmaceutical use of ketoamide-based compound
JP2023553810A (ja) Ｖｐｓ３４阻害剤の抗ウイルス活性
JP2023550638A (ja) ウイルス感染症の処置に使用するための、ｖｓｐ３４阻害剤としてのモルホリノ誘導体
Tatar et al. Synthesis, characterization and screening of antimicrobial, antituberculosis, antiviral and anticancer activity of novel 1, 3-thiazolidine-4-ones derived from 1-[2-(benzoylamino)-4-(methylthio) butyryl]-4-alkyl/arylalkyl thiosemicarbazides
US11730712B2 (en) Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease
CN103772231B (zh) 新颖化合物，其合成方法及治疗用途
JP2001502690A (ja) ピペリジン化合物
CN112218878A (zh) Ntcp抑制剂
RU2819346C1 (ru) Фармацевтическое применение соединения на основе кетоамида
DE69318725T2 (de) Quinuclidinderivate als squalene synthese inhibitoren
HK40085827A (en) Pharmaceutical use of ketoamide-based compound
CN106946888B (zh) 一种磺酰胺基衍生物及其在制备抗肿瘤药物中的用途
WO2016181894A1 (ja) 環状化合物
CN109153655A (zh) 用于预防或治疗心血管疾病的新型n-酰基脲衍生物和包含其的组合物
HK1115749A (en) Novel compounds and methods for synthesis and therapy
HK1120494B (en) Novel compounds and methods for synthesis and therapy

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU